References

  1. De Vlas SJ, Gryseels B. Underestimation of S mansoni prevalences. Parasitology Today. 1992; 8:274-7. This article on PubMed

  2. King CH, Muchiri EM, Ouma JH. Evidence against rapid emergence of praziquantel resistance in Schistosoma haematobium, Kenya. Emerg Infect Dis. 2000 Nov-Dec;6(6):585-94. This article on PubMed

  3. Ghoneim MA. Bilharziasis of the genitourinary tract. BJU Int. 2002 Mar;89 Suppl 1:22-30. This article on PubMed

  4. Raso G, N’Goran EK, Toty A, et al. Efficacy and side effects of praziquantel against Schistosoma mansoni in a community of western Cote d’Ivoire. Trans R Soc Trop Med Hyg. 2004 Jan;98(1):18-27. This article on PubMed

  5. Alonso D, Muñoz J, Gascón J, Valls ME, Corachan M. Failure of standard treatment with praziquantel in two returned travelers with Schistosoma haematobium infection. Am J Trop Med Hyg. 2006 Feb;74(2):342-4. This article on PubMed

  6. Silva IM, Thiengo R, Conceição MJ, Rey L, Lenzi HL, Pereira Filho E, Ribeiro PC. Therapeutic failure of praziquantel in the treatment of Schistosoma haematobium infection in Brazilians returning from Africa. Mem Inst Oswaldo Cruz. 2005 Jul;100(4):445-9. This article on PubMed

  7. Nimorsi OP, Egwunyenga AO, Bajomo DO. Survey of urinary schistosomiasis and trichomoniasis in a rural community in Edo State, Nigeria. J Commun Dis. 2001 Jun;33(2):96-101. This article on PubMed

  8. Caffrey CR. Chemotherapy of schistosomiasis: present and future. Curr Opin Chem Biol. 2007 Aug;11(4):433-9. This article on PubMed

  9. N'Goran EK, Gnaka HN, Tanner M, Utzinger J. Efficacy and side-effects of two praziquantel treatments against Schistosoma haematobium infection, among schoolchildren from Côte d'Ivoire. Ann Trop Med Parasitol. 2003 Jan;97(1):37-51. This article on PubMed

  10. Doenhoff MJ, Cioli D, Utzinger J. Praziquantel: mechanisms of action, resistance and new derivatives for schistosomiasis. Curr Opin Infect Dis. 2008 Dec;21(6):659-67. This article on PubMed